|
MOTILITY AND INVASION
|
5P01CA100324-08
|
$2,091,643
|
$209,164
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
MR Spectroscopy to Evaluate Liver Repopulation by Transplanted Hepatocytes
|
4R33CA121051-03
|
$490,349
|
$161,815
|
GUHA, CHANDAN
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Engineered self-destructing Salmonella as a colorectal cancer cure
|
1R21CA152456-01
|
$165,844
|
$165,844
|
Kong, Wei
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Targeted Polymer-Adenovirus Hybrids for Ablation of Bladder Cancer Disease
|
1R21CA143505-01A1
|
$202,158
|
$202,158
|
Rege, Kaushal
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Targeted Gene Therapy for Lymphoma
|
5R01CA113454-05
|
$267,784
|
$267,784
|
SMITH, BRUCE
|
AUBURN UNIVERSITY AT AUBURN
|
|
Modular internalizing molecules for treatment of more than one stage of malignanc
|
1R43CA141725-01A1
|
$183,938
|
$183,938
|
GREENBERG, MICHAEL
|
B3 BIO, INC.
|
|
PDX-1 is a Therapeutic Target for Pancreatic Cancer
|
5R01CA095731-08
|
$274,814
|
$137,407
|
BRUNICARDI, FRANCIS
|
BAYLOR COLLEGE OF MEDICINE
|
|
Translational Breast Cancer Research Training Program
|
5T32CA090221-08
|
$194,626
|
$48,657
|
FUQUA, SUZANNE
|
BAYLOR COLLEGE OF MEDICINE
|
|
Enhancing T Cell Therapy of Cancer
|
5P01CA094237-08
|
$1,992,319
|
$996,160
|
Heslop, Helen
|
BAYLOR COLLEGE OF MEDICINE
|
|
Role of Dietary Zinc Transporter ZIP4 in Pancreatic Cancer
|
1R01CA138701-01A1
|
$318,513
|
$159,257
|
LI, MIN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Pediatric Clinical Oncology Research Training Program
|
3K12CA090433-09S1
|
$134,042
|
$26,808
|
Poplack, David
|
BAYLOR COLLEGE OF MEDICINE
|
|
Pediatric Clinical Oncology Research Training Program
|
5K12CA090433-09
|
$614,521
|
$122,904
|
Poplack, David
|
BAYLOR COLLEGE OF MEDICINE
|
|
Engineered tumor-specific T cells Resist Hypoxic-Tumor Immunosuppressive Attacks.
|
1R01CA142664-01
|
$318,513
|
$159,257
|
YOTNDA, PATRICIA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Gene repression by HSF1 during hyperthermia and other stresses.
|
5R01CA077465-07
|
$227,020
|
$22,702
|
CALDERWOOD, STUART
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Targeting Leukemic Stem Cells
|
5R01CA138211-03
|
$532,557
|
$532,557
|
TENEN, DANIEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Mouse Models for Human Cancer
|
5U01CA084301-12
|
$749,022
|
$187,256
|
KUCHERLAPATI, RAJU
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Stem Cell-Engineered Tumor Immunity in Man
|
1P01CA132681-01A2
|
$3,043,786
|
$2,648,094
|
BALTIMORE, DAVID
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
|
Nanosystems Biology Cancer Center 2
|
1U54CA151819-01
|
$2,586,441
|
$672,475
|
HEATH, JAMES
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
|
Imaging of gene expression in glioblastoma
|
5R01CA109620-05
|
$277,775
|
$277,775
|
Basilion, James
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Hematopoietic Cell Transplantation for Hematologic Malignancies
|
3P01CA030206-27S3
|
$88,804
|
$17,761
|
Forman, Stephen
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Hematopoietic Cell Transplantation for Hematologic Malignancies
|
3P01CA030206-28S1
|
$91,675
|
$18,335
|
Forman, Stephen
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Hematopoietic Cell Transplantation for Hematologic Malignancies
|
3P01CA030206-28S3
|
$101,770
|
$20,354
|
Forman, Stephen
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Hematopoietic Cell Transplantation for Hematologic Malignancies
|
5P01CA030206-28
|
$3,041,125
|
$608,225
|
Forman, Stephen
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
A Pilot Study of 5-FC and Genetically-Modified Neural Stem Cells to Treat Gliomas
|
5R21CA137639-02
|
$365,200
|
$91,300
|
PORTNOW, JANA
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Elucidation of cancer pathways and druggable targets using mouse models.
|
5U01CA084294-12
|
$729,463
|
$72,946
|
Abate-Shen, Cory
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
System for Rapid Generation of Aptamers for Transplant Therapies
|
1R43CA150490-01
|
$99,996
|
$99,996
|
Qian, Karen
|
CYNVENIO BIOSYSTEMS, INC.
|
|
Mining B-catenin/BCL9 transcriptional complex for Multiple Myeloma therapeutics
|
1R01CA151391-01
|
$350,957
|
$175,479
|
CARRASCO, RUBEN
|
DANA-FARBER CANCER INSTITUTE
|
|
Invasive Behavior of Tumor Cells Producing Collagenase-1
|
5R01CA077267-09
|
$243,034
|
$48,607
|
BRINCKERHOFF, CONSTANCE
|
DARTMOUTH COLLEGE
|
|
Boosting anti-tumor immune responses by modulating genes with nanoparticles
|
5R21CA132026-02
|
$205,073
|
$205,073
|
Conejo-Garcia, Jose
|
DARTMOUTH COLLEGE
|
|
Targeting Translation Control in Malignant Glioma
|
5R01CA124756-04
|
$266,760
|
$266,760
|
GROMEIER, MATTHIAS
|
DUKE UNIVERSITY
|
|
Coordinating Cell Killing by Communication: Biological Control and Cancer Therapy
|
5R01CA118486-05
|
$208,402
|
$208,402
|
YOU, LINGCHONG
|
DUKE UNIVERSITY
|
|
Therapeutic VEGFR-2 Silencing via Targeted Nanoparticles
|
5F32CA132546-04
|
$55,790
|
$55,790
|
Greene, Rachel
|
EAST TENNESSEE STATE UNIVERSITY
|
|
Developmental Transcription Factors in Prostate Cancer
|
3R01CA106826-06S1
|
$71,517
|
$7,152
|
MORENO, CARLOS
|
EMORY UNIVERSITY
|
|
Developmental Transcription Factors in Prostate Cancer
|
5R01CA106826-06
|
$311,431
|
$31,143
|
MORENO, CARLOS
|
EMORY UNIVERSITY
|
|
MDM2 regulates XIAP gene expression in cancer treatment
|
5R01CA123490-03
|
$257,300
|
$64,325
|
ZHOU, MUXIANG
|
EMORY UNIVERSITY
|
|
Exploiting Biological Networks to Improve Clinical Treatment of Ovarian Cancer
|
1R01CA140323-01A1
|
$423,060
|
$211,530
|
GODWIN, ANDREW
|
FOX CHASE CANCER CENTER
|
|
Basis for Lymphomagenesis in Akt2 Transgenic Mice
|
5R01CA077429-11
|
$452,084
|
$113,021
|
TESTA, JOSEPH
|
FOX CHASE CANCER CENTER
|
|
Career Development in Pediatric and Medical Oncology
|
5K12CA076930-12
|
$534,606
|
$106,921
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Pediaric Oncology Research Training Program
|
5T32CA009351-32
|
$218,479
|
$43,696
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Hematopoietic Chemoprotection in Glioblastoma Patients
|
5R01CA114218-05
|
$445,303
|
$222,652
|
KIEM, HANS-PETER
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Seattle Cancer Consortium Breast SPORE
|
1P50CA138293-01A1
|
$2,300,000
|
$575,000
|
PORTER, PEGGY
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Targeted therapy of ALL with gene-modified central memory T cells
|
5R01CA136551-02
|
$560,754
|
$280,377
|
Riddell, Stanley
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Engineering enzymes for anti-tumor suicide gene therapy
|
5R01CA097328-08
|
$309,979
|
$309,979
|
STODDARD, BARRY
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Structural and Biophysical Characterization of Engineered Homing Endonucleases (C
|
5RL1CA133833-04
|
|
$0
|
STODDARD, BARRY
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Pacific Ovarian Cancer Research Consortium
|
5P50CA083636-12
|
$2,300,000
|
$575,000
|
Urban, Nicole
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
DNA Replication Control and Its Application to Selective Killing of Cancer Cells
|
4R00CA136555-02
|
$248,999
|
$82,170
|
ZHU, WENGE
|
GEORGE WASHINGTON UNIVERSITY
|
|
Anti-stathmin Bifunctional Small Hairpin RNA: Preclinical Dev't of High Potency,
|
N43CO100108-000
|
$199,045
|
$199,045
|
Tong, Alex
|
GRADALIS, INC.:1183475
|
|
Designing Lymph Nodes for Cancer Immunotherapy
|
1R01CA148995-01
|
$346,525
|
$346,525
|
MULE, JAMES
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Stem cell manipulation via HOX gene regulation
|
5R01CA090833-09
|
$280,779
|
$280,779
|
EMERSON, STEPHEN
|
HAVERFORD COLLEGE
|
|
ADAM 17 and glioma-tumor progression and treatment
|
5R01CA129446-02
|
$300,875
|
$99,289
|
JIANG, FENG
|
HENRY FORD HEALTH SYSTEM
|
Total relevant funding to Gene Therapy for this search: $72,081,945
|